Trial Profile
Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2023
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DapaT1DM
- 07 Apr 2015 Planned End Date changed from 1 Jan 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.
- 07 Apr 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 13 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.